SCNX — Scienture Holdings Share Price
0.000.00%
Last trade - 00:00- $12.39m
- $15.39m
- $0.14m
- 26
- 36
- 14
- 14
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.16 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 90.68 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -17.74% | ||
| Return on Equity | -45.83% | ||
| Operating Margin | -12588.57% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 17.12 | 9.89 | 10.25 | 8.27 | 0.14 | n/a | n/a | -55.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.
Directors
- Surendra Ajjarapu CHM (50)
- Prashant Patel PRE (46)
- Howard Doss CFO (67)
- Donald Fell IND (74)
- Christine Jennings IND (75)
- Charles Pope IND (70)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 15th, 2005
- Public Since
- February 18th, 2020
- No. of Shareholders
- 90
- No. of Employees
- 14
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 12,515,019
- Address
- 2420 Brunello Trace, LUTZ, 33558
- Web
- https://www.trxadehealth.com/
- Phone
- +1 8136013533
- Auditors
- Malone Bailey, LLP
Upcoming Events for SCNX
Q2 2025 TRxADE Health Inc Earnings Release
Similar to SCNX
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Agriforce Growing Systems
NASDAQ Capital Market
Akari Therapeutics
NASDAQ Capital Market
Akebia Therapeutics
NASDAQ Capital Market
ASP Isotopes
NASDAQ Capital Market
FAQ
What is the Scienture Holdings share price?
As of Today at 23:07 UTC, shares in Scienture Holdings are trading at $0.99. This share price information is delayed by 15 minutes.
How has the Scienture Holdings share price performed this year?
Shares in Scienture Holdings last closed at $0.99 and the price had moved by -83.05% over the past 365 days. In terms of relative price strength the Scienture Holdings share price has underperformed the S&P500 Index by -84.36% over the past year.
What are the analyst and broker recommendations for Scienture Holdings?
The overall consensus recommendation for Scienture Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Scienture Holdings dividend yield?
Scienture Holdings does not currently pay a dividend.
Does Scienture Holdings pay a dividend?
Scienture Holdings does not currently pay a dividend.
When does Scienture Holdings next pay dividends?
Scienture Holdings does not currently pay a dividend.
How do I buy Scienture Holdings shares?
To buy shares in Scienture Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Scienture Holdings?
As of the previous close price of $0.99, shares in Scienture Holdings had a market capitalisation of $12.39m.
Where are Scienture Holdings shares listed?
Here are the trading details for Scienture Holdings:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SCNX
What kind of share is Scienture Holdings?
Based on an overall assessment of its quality, value and momentum Scienture Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Scienture Holdings share price forecast for 2025?
The analyst consensus target price for shares in Scienture Holdings is $6.75. That is 581.82% above the last closing price of $0.99.
Analysts covering Scienture Holdings currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Scienture Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Scienture Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -85.9%.
As of the last closing price of $0.99, shares in Scienture Holdings were trading -84.04% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Scienture Holdings PE Ratio?
The Scienture Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Scienture Holdings?
Scienture Holdings' management team is headed by:
- Surendra Ajjarapu - CHM
- Prashant Patel - PRE
- Howard Doss - CFO
- Donald Fell - IND
- Christine Jennings - IND
- Charles Pope - IND